Atlas Trials

Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis

Clinical trial NCT01408810 · COMPLETED

Trial details

NCT number
NCT01408810
Sponsor
Grupo de Estudo da Doença Inflamatória Intestinal
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2011-02-01
Primary completion
2012-11-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.